YERXA BENJAMIN R sold $22K of IRD
YERXA BENJAMIN R (President) sold 7,429 shares of Opus Genetics, Inc. (IRD) at $2.97 on 2026-07-23.
How this was made
The 30-second read
Why it matters
The newest fact is the specific open-market sale details by the President, including shares, price, and post-transaction holdings. The disclosure does not provide new operational or financial information about the company.
Market read
Traders may note insider selling as a minor sentiment datapoint, but the transaction size is small and lacks fundamental drivers.
What to watch
No 10b5-1 plan is stated, but the article provides no context on taxes, option exercises, or prior planned sales, limiting inference.
Background
This is an SEC Form 4 insider transaction disclosure for Opus Genetics, Inc. (IRD).
Ticker impact
Opus Genetics insider Form 4 shows President sold 7,429 shares at $2.97 on 2026-07-23, totaling about $22.1K.
Likely limited near-term price impact; any effect is sentiment-only and typically fades.
The filing is a disclosed transaction size of roughly $22K and does not include new company performance, guidance, or material corporate events.
Market effects
No clear sector read-through from a small, routine insider sale.
None indicated.
None indicated.
Counterpoint
The sale could be for diversification or personal liquidity needs and may not signal reduced confidence, especially with a small value.
Key entities
- issuerOpus Genetics, Inc.
Subject of the Form 4 insider transaction disclosure.
- insiderYERXA BENJAMIN R
President, officer/director, reported open-market sale of shares.
